New York Gov. Hochul declares state disaster emergency over monkeypox

New York Gov. Hochul declares state disaster emergency over monkeypox


People wait on line to register for a monkeypox vaccination shot on July 29, 2022 in New York City.

John Smith | Corbis News | Getty Images

New York Gov. Kathy Hochul declared a state disaster emergency Friday night over the continued spread of monkeypox.

She said the emergency declaration would lead to swifter response and better vaccination distribution. It came a day after the state declared monkeypox an imminent threat to public health in New York.

“I am declaring a State Disaster Emergency to strengthen our ongoing efforts to confront the monkeypox outbreak,” Hochul tweeted Friday.

Hochul indicated New York is an emerging center for the virus, which manifests in symptoms of rashes and lesions across the body, extremities and genitals.

“More than one in four monkeypox cases in this country are in New York,” she wrote, “currently having a disproportionate impact on at-risk groups.”

The virus, spread through physical contact, can develop flu-like symptoms, and its initial impacts can last as long as four weeks.

“We are working around the clock to secure more vaccines, expand testing capacity, and educate New Yorkers on how to stay safe,” Hochul said.



Source

Eli Lilly to start late-stage trials on amylin obesity drug after it shows up to 20% weight loss in study 
Health

Eli Lilly to start late-stage trials on amylin obesity drug after it shows up to 20% weight loss in study 

Eli Lilly Biotechnology Center is shown in San Diego, California, March 1, 2023. Mike Blake | Reuters Eli Lilly on Thursday said it will start late-stage trials on its experimental amylin obesity drug next month after it showed encouraging results in a mid-stage study. The highest dose of the weekly injection, called eloralintide, helped patients […]

Read More
Healthy Returns: What to know about Pfizer and Novo Nordisk’s bidding war over obesity biotech Metsera
Health

Healthy Returns: What to know about Pfizer and Novo Nordisk’s bidding war over obesity biotech Metsera

A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Pfizer and Novo Nordisk are in a takeover clash over the obesity biotech Metsera, with both pharmaceutical giants raising their bids for the startup as of Monday.  […]

Read More
Pfizer tops estimates, raises profit guidance even as sales fall
Health

Pfizer tops estimates, raises profit guidance even as sales fall

Smith Collection | Archive Photos | Getty Images Pfizer on Thursday reported third-quarter earnings and revenue that topped estimates and hiked its full-year profit guidance, as cost cuts helped to outweigh declining sales for the period. The pharmaceutical giant now expects its full-year adjusted profit to come in between $3 and $3.15 per share, up […]

Read More